Immunex Corporation

Zhengbin Yao

Melanie K Spriggs

William Christian Fanslow, Iii

Richard Jeffrey Armitage

Mark R Alderson

Isolated receptors for IL-17, DNA's encoding such receptors, and pharmaceutical compositions made therefrom, are disclosed. The isolated receptors can be used to regulate an immune response.

Methods of treating asthma by administering interleukin-17 receptor

Methods of treating allergy by administering interleukin-17 receptor

Methods of treating autoimmune disease by administering interleukin-17 receptor

Isolated receptors for IL-17, DNA's encoding such receptors, pharmaceutical compositions made therefrom, detection assays and methods of inhibiting binding of the receports are disclosed. The isolated receptors can be used to regulate an immune response.

Assay kits for detection and methods of inhibiting IL-17 binding

Isolated receptors for IL-17, DNA's encoding such receptors, and pharmaceutical compositions made therefrom, and methods of treatment using the IL-17 receptors are disclosed. The isolated receptors can be used to regulate an immune response.

Methods of treating immune and inflammatory response with IL-17 receptors

Receptor that binds IL-17

Isolated receptors for IL-17, DNA's encoding such receptors, antibodies to such receptors and pharmaceutical compositions made therefrom, are disclosed. The isolated receptors can be used to regulate an immune response.

Antibodies to the IL-17 receptor

Isolated viral proteins, and compositions made therefrom, are disclosed which are capable of binding to Class II Major Histocompatibility Complex antigen, thereby functioning to inhibit an antigen-specific response. The isolated viral proteins also act as superantigens.

Growing community of inventors

Lafayette, CO, United States of America

Zhengbin Yao